Focuses on multi‑omic profiling of cancer—integrating genomics, epigenetics and 3D genome organization with exosome signals and immune–stromal crosstalk—to deliver predictive biomarkers and actionable diagnostics. Develops quantitative chromatin‑sequencing methods and computational data pipelines.